In experimental autoimmune uveitis models, Irisin has been shown to modulate microglial polarization and mitigate disease severity by suppressing Th1 and Th17 cells responses, as well as reducing M1 microglial polarization through the HIF-1α signaling pathway (Wang MQ. The gene discussed is HIF1A; the disease is autoimmune uveitis.